Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases
The Journal of Allergy and Clinical Immunology: In Practice · 2024
DOI: 10.1016/j.jaip.2024.06.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Mian B Khalid und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. Hauptthemen laut MEDLINE: Budesonide, Enteritis, Eosinophilia, Gastritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
- National Cancer Institute, National Institutes of Health, Bethesda, Md.
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. Electronic address: sheila.kumar@nih.gov.
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Khalid, M. B., Sharma, D., Howard, A., Akbulut, D., Sampaio de Melo, M., Quezado, M. M., Castillo, P. A., Cuevas, G. A., Klion, A. D., Khoury, P., Constantine, G. M., & Kumar, S. (2024). Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.06.028
Vancouver
Khalid MB, Sharma D, Howard A, Akbulut D, Sampaio de Melo M, Quezado MM, et al. Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2024.06.028
BibTeX
@article{Khalid2024,
author = {Khalid, Mian B and Sharma, Disha and Howard, Amari and Akbulut, Dilara and Sampaio de Melo, Michelly and Quezado, Martha M and Castillo, Perla A and Cuevas, Gustavo A and Klion, Amy D and Khoury, Paneez and Constantine, Gregory M and Kumar, Sheila},
title = {Gastrointestinal segmental remission with oral budesonide therapy for eosinophilic gastrointestinal diseases},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
doi = {10.1016/j.jaip.2024.06.028}
}
EUVIMED